Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT01348074
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 104 participants
- Sponsor
- Registry
-
NCT01348074
-
- Main results
- Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01348074. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist
- Acronym
- DOSIDO
- Condition
- Atrial Fibrillation
- Condition
- Venous Thromboembolism
- Condition
- Heart Valve Disease
- Condition
- Surgery
- Intervention (Drug)
- Double dose
- Lead sponsor
- McMaster University
Record details
- Record id
cardio:ct-nct01348074- Content hash
fd0c3289f8e44ecd5c5651a23bfb2b8a5d8f3f39c0e2d6129eaa95c9f040e17f